Old Web
English
Sign In
Acemap
>
authorDetail
>
Julio Rosenstock
Julio Rosenstock
AmeriCorps VISTA
Endocrinology
Biology
Internal medicine
Liraglutide
Body weight
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1014-P: Relationship between Glycemic Control and Weight Loss with Once-Weekly Efpeglenatide in Uncontrolled Type 2 Diabetes: A Subanalysis of EXCEED 203
2019
Diabetes
Julio Rosenstock
Cristobal Morales
Ulrich Wendisch
George E. Dailey
Michael E. Trautmann
Marcus Hompesch
In Young Choi
Jahoon Kang
John A. Stewart
Ike Ogbaa
Christopher H. Sorli
Kun-Ho Yoon
Show All
Source
Cite
Save
Citations (0)
1023-P: Do Baseline Characteristics Impact Efficacy of Efpeglenatide QW in Uncontrolled Type 2 Diabetes?
2019
Diabetes
George E. Dailey
Julio Rosenstock
Cristobal Morales
Ulrich Wendisch
Michael E. Trautmann
Marcus Hompesch
In Young Choi
Jahoon Kang
Christopher H. Sorli
Ike Ogbaa
John A. Stewart
Kun-Ho Yoon
Show All
Source
Cite
Save
Citations (0)
Exploring the Efficacy of Efpeglenatide, a Weekly Glucagon–Like Peptide–1 Receptor Agonist (GLP–1RA)–Evidence from Preclinical, Modeling, and Clinical Studies
2018
Diabetes
Julio Rosenstock
Michael E. Trautmann
Marcus Hompesch
In Young Choi
Jahoon Kang
Kun-Ho Yoon
Christopher H. Sorli
Show All
Source
Cite
Save
Citations (0)
1